Last reviewed · How we verify

NCT05917886

Auditory Beat Stimulation and Behavioural Variant of Frontotemporal Dementia

Completed NA Last updated 26 June 2023
What this trial tests

NA trial testing Auditory beat stimulation: 8Hz monaural beat stimulation in Anxiety in 11 participants. Completed in 1 September 2021.

Timeline
1 January 2021
Primary endpoint
1 August 2021
1 September 2021

Quick facts

Lead sponsorUniversity Hospital, Bonn
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposebasic science
Enrollment11
Start date1 January 2021
Primary completion1 August 2021
Estimated completion1 September 2021
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bonn

Who can join

Eligibility, any sex, with Anxiety or bvFTD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to examine the effects of auditory beat stimulation on anxiety in patients diagnosed with bvFTD. Main aims are: * to ascertain whether anxiety in bvFTD patients can be modulated using auditory beat stimulation * to investigate patterns of anxiety and mind wandering in bvFTD patient population Patients were asked to complete a number of questionnaires relating to well-being and mind wandering, as well as to listen daily to audio files of beat stimulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other University Hospital, Bonn trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05917886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing